18 juillet 2012

PDA : A Survey of Industry Practice for the Visual Inspection of Injectable Products

Document current industry practice for visual inspection of injectable products. Compare results with previous surveys conducted in 1996 and 2003.

57 questions
• Blinded response
• 230 companies/sites contacted
• 21 responded (9%)

Download file

Read more ...

Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventin Cross-Contamination
EudraGMP Database now also comprises GDP Information
Revision of the EU GMP Guide : EU Commission Proposal for Chapter 6 - Quality Control
Importation of active substances for medicinal products for human use
HAS Description de la régulation de la promotion des produits de santé en France
CDER / CBER Guidance Formal Dispute Resolution: Appeals Above the Division Level
ICH M7 Assessment And Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk
Good Distribution Practice of Medicinal Product for Human Use - Mars 2013
USP 39(2) In-Process Revision (Mar-Apr 2013)
Guideline on the principles of Good Distribution Practices (GDP) for active substances for medicinal products for human use